31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
The novel coronavirus (COVID-19) has implications for multiple workplace concerns, including health ...
Read More >
In today’s highly competitive healthcare environment, investors may find themselves in an auction p...
Read More >
Seyfarth Synopsis: Effective January 1, 2020, the Illinois Workplace Transparency Act (WTA) amended ...
Read More >
Welcome to the newest addition to the Compliance Podcast Network, Compliance and Coronavirus. In thi...
Read More >
This article is an update to prior publications from Littler’s Workplace Policy Institute regarding...
Read More >
As 2020 approaches, employers in New England may want to review their noncompetition agreements to d...
Read More >